OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
BSEM
BioStem Technologies, Inc.
Common Stock
13.97
-0.05
-0.36%
13.97 / 14.15 (100 x 200)
Real-Time Best Bid & Ask: 05:00pm 06/11/2025
Delayed (15 Min) Trade Data: 12:00am 06/11/2025
14.20
13.754 - 14.20
27,649
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
OTC NQB | 13.97 | 100 | 06/11 |
VIRTU Americas LLC | 13.95 | 1,000 | 06/11 |
Puma Capital, LLC | 13.90 | 100 | 06/11 |
StoneX Financial Inc. | 13.90 | 100 | 06/11 |
CANACCORD GENUITY LLC. | 13.89 | 709 | 06/11 |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
Citadel Securities | 14.15 | 200 | 06/11 |
VIRTU Americas LLC | 14.25 | 300 | 06/11 |
G1 Execution Services, LLC | 14.35 | 200 | 06/11 |
StoneX Financial Inc. | 14.35 | 100 | 06/11 |
CANACCORD GENUITY LLC. | 14.37 | 1,112 | 06/11 |
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 06/11/2025 | 15:57:24 | 13.97 | 0.00 | 400 |
| 06/11/2025 | 15:57:19 | 13.97 | -0.01 | 100 |
| 06/11/2025 | 15:56:54 | 13.979 | 0.00 | 100 |
| 06/11/2025 | 15:56:10 | 13.979 | -0.02 | 100 |
| 06/11/2025 | 15:55:19 | 14.00 | 0.00 | 100 |
News
BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review ProcessGlobeNewswire | 06/03/2025
BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewswire | 05/29/2025
BioStem Announces Notice of Allowance for Three New U.S. Patent ApplicationsGlobeNewswire | 05/28/2025
Filings and Disclosure
Company Description
BioStem Technologies is a leading innovator focused on harnessing the natural properties
of perinatal tissue in the development, manufacture, and commercialization of allografts
for regenerative therapies. The Company is focused on manufacturing products that
change lives, leveraging its proprietary BioRetain processing method. BioRetain has
been developed by applying the latest research in regenerative medicine, focused on
maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and
accredited by the American Association of Tissue Banks ("AATB"). These systems and
procedures are established per current Good Tissue Practices ("cGTP") and current Good
Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE,
VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is
processed at the Company's FDA registered and AATB accredited site in Pompano
Beach, Florida.
Videos
BioStem Technologies Reports
BioStem Technologies Reports
More
Pink Current Information
The security is currently undergoing promotional activity.
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
50.72
Change
0.02 (0.04%)
Bid
50.70
Ask
50.75
Volume
1336
Time
00:00
